Literature DB >> 9802724

Gestational diabetes: do lean young caucasian women need to be tested?

R G Moses1, J Moses, W S Davis.   

Abstract

OBJECTIVE: The American Diabetes Association has recommended that pregnant women with low-risk factors need not be tested for gestational diabetes mellitus (GDM). The aim of this study was to determine the prevalence of GDM in women with low-risk factors and to see if the pregnancy outcomes of women with GDM from a low-risk group were different from the outcomes of other women with GDM. RESEARCH DESION AND METHODS: Over an 18-month period, all pregnant women were offered a test for GDM using a 75-g glucose tolerance test at the beginning of the 3rd trimester. GDM was diagnosed if the 2-h glucose level was > or =8.0 mmol/l. The prevalence of GDM was determined in women with defined low-risk factors (Caucasian ethnic origin, age <25 years, and BMI <25 kg/m2). The pregnancy outcomes of women with GDM from a low-risk group were compared with those of other women with GDM.
RESULTS: From a tested population of 2,907 women, 573 were identified as coming from a low-risk group. The prevalence of GDM in this low-risk group was 2.8%. The pregnancy outcomes of women with GDM from a low-risk group were no different from the pregnancy outcomes of other women with GDM, with respect to frequency of insulin use, units of insulin per day, morbidity, emergency caesarian section, and the percentage of both large- and small-for-gestational-age babies. In our population, if low-risk women were excluded, 80% of women would still require testing and nearly 10% of all cases of GDM would be missed.
CONCLUSIONS: Women from a low-risk group have a 2.8% prevalence rate of GDM. The pregnancy outcomes of women with GDM from a low-risk group are similar to the outcomes of other women with GDM. Concerning the use of the 75-g glucose tolerance test in pregnancy, the recommendation not to test women from a low-risk group requires further evaluation in different populations before it can be endorsed.

Entities:  

Mesh:

Year:  1998        PMID: 9802724     DOI: 10.2337/diacare.21.11.1803

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  10 in total

Review 1.  Nutrition and pregnancy: the link between dietary intake and diabetes.

Authors:  Lois Jovanovic
Journal:  Curr Diab Rep       Date:  2004-08       Impact factor: 4.810

2.  C-reactive protein and tumor necrosis factor-alpha in gestational hyperglycemia.

Authors:  S Bo; A Signorile; G Menato; R Gambino; C Bardelli; M L Gallo; M Cassader; M Massobrio; G F Pagano
Journal:  J Endocrinol Invest       Date:  2005-10       Impact factor: 4.256

3.  Guidelines for the detection of diabetes mellitus--diagnostic criteria and rationale for screening.

Authors:  Hans Schneider; Jonathan Shaw; Paul Zimmet
Journal:  Clin Biochem Rev       Date:  2003-08

4.  Universal versus selective screening for detection of gestational diabetes mellitus in a malaysian population.

Authors:  N Idris; Ch Che Hatikah; Mz Murizah; Mn Rushdan
Journal:  Malays Fam Physician       Date:  2009-08-31

Review 5.  Achieving euglycaemia in women with gestational diabetes mellitus: current options for screening, diagnosis and treatment.

Authors:  Lois Jovanovic
Journal:  Drugs       Date:  2004       Impact factor: 9.546

6.  Point: Universal screening for gestational diabetes mellitus.

Authors:  Robert G Moses; N Wah Cheung
Journal:  Diabetes Care       Date:  2009-07       Impact factor: 17.152

Review 7.  Risk factor screening to identify women requiring oral glucose tolerance testing to diagnose gestational diabetes: A systematic review and meta-analysis and analysis of two pregnancy cohorts.

Authors:  Diane Farrar; Mark Simmonds; Maria Bryant; Debbie A Lawlor; Fidelma Dunne; Derek Tuffnell; Trevor A Sheldon
Journal:  PLoS One       Date:  2017-04-06       Impact factor: 3.240

8.  Applying current screening tools for gestational diabetes mellitus to a European population: is it time for change?

Authors:  Gloria E Avalos; Lisa A Owens; Fidelma Dunne
Journal:  Diabetes Care       Date:  2013-06-11       Impact factor: 19.112

9.  Gestational diabetes mellitus: to screen or not to screen?: Is this really still a question?

Authors:  David Simmons; Robert G Moses
Journal:  Diabetes Care       Date:  2013-10       Impact factor: 19.112

10.  A Clinical Update on Gestational Diabetes Mellitus.

Authors:  Arianne Sweeting; Jencia Wong; Helen R Murphy; Glynis P Ross
Journal:  Endocr Rev       Date:  2022-09-26       Impact factor: 25.261

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.